Maharashtra’ Food and Drug Administration has ordered an FIR against eCommerce giant Snapdeal founders Kunal Bahl and other directors for allegedly selling prescription based drugs on the website. The FDA had asked the company to furnish documents pertaining to the distribution and sale
Recent Posts
- Pharma Titans & Healthcare Visionaries Honoured — Healthcare Super Brand Awards 2026 Redefine Global Standards at Pharma Leaders Annual Awards
- MGM Institute of Health Sciences Honored as Asia’s Most Prestigious Health Sciences & Patient Centric Institution 2026
- THE ILLUSION OF TRUCE: Decoding the U.S.–Iran War and the Myth of a Quick End
- The $1.1 Billion Paradox: Inside Emcure’s High-Stakes Legal Warfare, US FDA Scrutiny, and Leadership Exodus
- Why Healthcare in India Needs Urgent Attention?










